Methods and Apparatus for Effectuating a Lasting Change in a Neural Function of a Patient, Including Via Mechanical Force on Neural Tissue

• US 20080275526A1
• Filed: 03/06/2006
• Published: 11/06/2008
• Est. Priority Date: 03/04/2005
• Status: Active Grant

• Current Assignee: Functional Neuroscience Inc.
• Original Assignee: Functional Neuroscience Inc.
• Inventors: Lozano, Andres M.
• Granted Patent: US 8,244,347 B2
• Time in Patent Office: Days
• US Class Current: 607/45
• CPC Class Codes: A61M 2205/05 combined with other kinds of therapy
• CPC Class Codes: A61M 2205/054 with electrotherapy
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/172 electrical or electronic A61M5/16804, A61M5/16831 take precedence
• CPC Class Codes: A61N 1/0529 Electrodes for brain stimulation
• CPC Class Codes: A61N 1/0531 Brain cortex electrodes
• CPC Class Codes: A61N 1/0534 Electrodes for deep brain stimulation
• CPC Class Codes: A61N 1/0539 Anchoring of brain electrode systems, e.g. within burr hole
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/361 Phantom sensations, e.g. tinnitus
• CPC Class Codes: A61N 1/3787 from an external energy source

Abstract

Methods and apparatus for effectuating a lasting change in a neural function of a patient, including via mechanical force on neural tissue, are disclosed. An apparatus in accordance with one embodiment includes an implantable force delivery device that is changeable between a first state in which the force delivery device applies a first mechanical force to neural tissue, and the second state in which the force delivery device applies no mechanical force or a second mechanical force less than the first mechanical force to the neural tissue, while the force delivery device is implanted. An actuator can be coupled to the force delivery device with a communication link to change the state of the force delivery device, and a controller can be operably coupled to the actuator to automatically direct the force delivery device to change repeatedly between the first and second states while the force delivery device is implanted.

Claims

1. An implantable patient treatment apparatus, comprising:

an implantable force delivery device that is changeable between a first state in which the force delivery device applies a first mechanical force to neural tissue, and a second state in which the force delivery device applies no mechanical force or a second mechanical force less than the first mechanical force to the neural tissue while the force delivery device is implanted;

an actuator coupled to the force delivery device with a communication link to change the state of the force delivery device; and

a controller operatively coupled to the actuator to automatically direct the force delivery device to change repeatedly between the first and second states while the force delivery device is implanted.

2. The apparatus of claim 1 wherein the force delivery device applies a changing mechanical force when in the first state, and wherein the force delivery device applies an average mechanical force when in the second state that is less than an average mechanical force applied when in the first state.

3. The apparatus of claim 1 herein the force delivery device is inflatable to change between the first and second states, wherein the actuator includes a fluid reservoir, and wherein the communication link includes a fluid conduit.

4. The apparatus of claim 1 wherein the controller and the actuator are configured to direct the force delivery device to apply a maximum constant pressure of from about 26.5 gm/cm² to about 30 gm/cm².

5. The apparatus of claim 1 wherein the controller and the actuator are configured to direct the force delivery device to apply a maximum intermittent pressure of from about 53 gm/cm² to about 60 gm/cm².

6. The apparatus of claim 1 wherein the controller includes a computer-readable medium having instructions for directing the action of the actuator.

7. The apparatus of claim 1 wherein the controller is configured to direct the force delivery device to apply a force in accordance with a consistent schedule on a repeated, intermittent basis.

8. The apparatus of claim 1 wherein the controller is configured to direct the force delivery device to apply a force for periods of time that vary from one period to another.

9. The apparatus of claim 1, further comprising a drug delivery device coupleable to a source of patient drugs and coupled to the controller, wherein the controller is configured to coordinate the change in state of the force delivery device with the application of drugs to the patient.

10. The apparatus of claim 1, further comprising an electrode coupled to a source of electrical potential, the electrode being configured to apply an electrical current to the patient.

11. The apparatus of claim 10 wherein the electrode is carried by the implantable force delivery device.

12. The apparatus of claim 10 wherein the controller is coupled to both the electrode and the actuator, and wherein the controller is configured to direct electrical energy to the electrode at first level when the force delivery device is in the second state, and wherein the controller is configured to direct no electrical energy or electrical energy at a second level less than the first level when the force delivery device is in the first state.

13. The apparatus of claim 1, further comprising an implantable electrode coupled to the controller to provide to the controller a feedback signal indicative of electrical activity in the patient.

14. The apparatus of claim 1, further comprising a feedback sensor coupled to the controller, the feedback sensor being configured to sense a characteristic of the patient, and wherein the controller is configured to receive a signal from the feedback sensor and direct a change in the state of the force delivery device based at least in part on the signal received from the feedback sensor.

15. The apparatus of claim 1, further comprising a patient-controllable feedback device coupled to the controller, and wherein the controller is configured to receive a signal from the feedback device and direct a change in state of the force delivery device based at least in part on the signal received from the feedback device.

16. The apparatus of claim 1 wherein the force delivery device is configured to be implanted at a cortical location.

17. An implantable patient treatment apparatus, comprising:

implantable force delivery means for applying a mechanical force to neural tissue, the force delivery means being changeable between a first state in which the force delivery means applies a first mechanical force to neural tissue, and a second state in which the force delivery means applies no mechanical force or a second mechanical force less than the first mechanical force to the neural tissue while the force delivery means is implanted;

actuation means for changing the state of the force delivery means; and

control means operatively coupled to the actuation means for automatically directing the force delivery means to repeatedly change state while the force delivery means is implanted.

18. The apparatus of claim 17 wherein the force delivery means applies a changing mechanical force when in the first state, and wherein the force delivery means applies an average mechanical force when in the second state that is less than an average mechanical force applied when in the first state.

19. The apparatus of claim 17 wherein the force delivery means is inflatable to change between the first and second states, and wherein the actuator means includes a fluid reservoir.

20. The apparatus of claim 17 wherein the control means includes a computer-readable medium having instructions for directing the action of the actuator.

21. The apparatus of claim 17, further comprising an electrode coupled to a source of electrical potential, the electrode being configured to apply an electrical current to the patient.

22. The apparatus of claim 21 wherein the electrode is carried by the implantable force delivery means.

23. A method for treating a patient, comprising:

directing an implanted force delivery device to repeatedly alternate between a first state and a second state while the force delivery device is implanted in a patient, wherein;

when the force delivery device is in the first state, it applies a first mechanical force to target neural tissue of the patient; and

when the force delivery device is in the second state, it applies no mechanical force or a second mechanical force less than the first mechanical force to the target neural tissue over the course of a treatment regimen to achieve a patient benefit.

24. The method of claim 23 wherein the force delivery device applies a changing mechanical force when in the first state, and wherein the force delivery device applies an average mechanical force when in the second state that is less than an average mechanical force applied when in the first state.

25. The method of claim 23, further comprising identifying a target site at which the target neural tissue is located.

26. The method of claim 23, further comprising implanting the force delivery device at least proximate to the target neural tissue.

27. The method of claim 23 wherein directing the force delivery device includes automatically directing the force delivery device.

28. The method of claim 23 wherein directing the force delivery device is carried out by a computer-readable medium.

29. The method of claim 23, further comprising determining whether the patient realizes a therapeutic benefit while the force delivery device applies no mechanical force or a second mechanical force less than the first mechanical force.

30. The method of claim 29, further comprising determining when a patient symptom level meets or exceeds a threshold level.

31. The method of claim 23, further comprising:

determining when a patient symptom level meets or exceeds a threshold level; and

changing a characteristic of a manner in which the force delivery device applies a mechanical force to the target neural tissue based at least in part on determining that the patient symptom level meets or exceeds the threshold level.

32. The method of claim 23 wherein directing the force delivery device to apply a first mechanical force to the neural tissue is based at least in part on a contemporaneous patient request.

33. The method of claim 23 wherein directing the force delivery device to apply no mechanical force or a second mechanical force less than the first mechanical force is based at least in part on a contemporaneous patient request.

34. The method of claim 23, further comprising applying electrical stimulation, a drug infusion or both to the patient as part of a treatment regimen that includes the application of the mechanical force.

35. The method of claim 34 wherein applying electrical stimulation, a drug infusion or both is based at least in part on a contemporaneous patient request.

36. The method of claim 34 wherein applying electrical stimulation, a drug infusion or both is carried out at a site spaced apart from the target neural tissue.

37. The method of claim 23, further comprising applying electrical stimulation to the patient as part of a treatment regimen that includes the application of the mechanical force.

38. The method of claim 37 further comprising coordinating changes in the force applied by the force delivery device with changes in the electrical stimulation applied to the patient.

39. The method of claim 23, further comprising selecting the neural tissue to include cortical tissue.

40. The method of claim 23, further comprising selecting the neural tissue to include subdural structures.

41. The method of claim 23, further comprising selecting the neural tissue to include spinal tissue.

42. The method of claim 23, further comprising selecting the neural tissue to include peripheral neural tissue.

43. The method of claim 23 wherein when the force delivery device is in the first state, it applies a mechanical pressure of less than about 30 gm/cm² for less than 60 minutes.

44. The method of claim 23 wherein when the force delivery device is in the first state, it applies a mechanical pressure of less than 60 gm/cm² for less than 10 minutes.

45. The method of claim 23 wherein an electrode of the force delivery device contacts the target neural tissue and applies the force.

46. The method of claim 23 wherein directing the implanted force delivery device to repeatedly alternate between a first state and a second state includes directing a change in shape of the force delivery device.

47. The method of claim 23, further comprising automatically sensing a state of the patient and wherein directing the alternation of states of the implanted force delivery device is based at least in part on the sensed state of the patient.

48. A method for treating a patient, comprising:

identifying a patient dysfunction;

identifying a corresponding target location of the brain that is associated with the dysfunction; and

applying a therapy at the target location, the therapy including at least one of an electrical stimulation, a chemical infusion, and a mechanical force.

49. The method of claim 48 wherein applying a therapy includes applying an intermittent mechanical force.

50. The method of claim 48 wherein identifying a patient dysfunction includes identifying at least one of schizophrenia and an auditory hallucination, and wherein identifying a target location includes identifying at least one of the cortex and an auditory pathway.

51. The method of claim 48 wherein identifying a patient dysfunction includes identifying Tourette'"'"'s syndrome, and wherein identifying a target location includes identifying at least one of the motor cortex, the premotor cortex, the supplementary motor cortex, the motor thalamus and the pallidum.

52. The method of claim 48 wherein identifying a patient dysfunction includes identifying at least one of depression and a mood disorder, and wherein identifying a target location includes identifying at least one of the orbital frontal cortex, the prefrontal cortex, and the dorsolateral prefrontal cortex.

53. The method of claim 48 wherein identifying a patient dysfunction includes identifying attention deficit/hyperactivity disorder, and wherein identifying a target location includes identifying at least one of the frontal cortex and the prefrontal cortex.

54. The method of claim 48 wherein identifying a patient dysfunction includes identifying at least one of a substance dependency and an eating disorder, and wherein identifying a target location includes identifying at least one of the following locations:

cortical projections to the nucleus accumbens, subcortical projections to the nucleus accumbens, the nucleus accumbens and the ventral tegmental area.

55. The method of claim 48 wherein identifying a patient dysfunction includes identifying a movement disorder including generalized dystonia, focal dystonia, writer cramp, myoclonus, tremor, chorea and hemibalism and wherein identifying a target location includes identifying at least one of the following locations:

motor cortex, the premotor cortex, the supplementary motor cortex, the motor thalamus, the motor pallidum, the subthalamic nucleus, the zona incerta and the striatum.